- Home
- INSG vs CATX Comparison
INSG vs CATX Comparison
Compare INSG & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSG
- CATX
- Stock Information
- Founded
- INSG 1996
- CATX 1983
- Country
- INSG United States
- CATX United States
- Employees
- INSG N/A
- CATX N/A
- Industry
- INSG Telecommunications Equipment
- CATX Medical/Dental Instruments
- Sector
- INSG Telecommunications
- CATX Health Care
- Exchange
- INSG Nasdaq
- CATX Nasdaq
- Market Cap
- INSG 237.1M
- CATX 239.0M
- IPO Year
- INSG 2000
- CATX N/A
- Fundamental
- Price
- INSG $16.71
- CATX $2.74
- Analyst Decision
- INSG Buy
- CATX Strong Buy
- Analyst Count
- INSG 3
- CATX 10
- Target Price
- INSG $15.00
- CATX $12.30
- AVG Volume (30 Days)
- INSG 363.6K
- CATX 1.7M
- Earning Date
- INSG 11-06-2025
- CATX 11-10-2025
- Dividend Yield
- INSG N/A
- CATX N/A
- EPS Growth
- INSG N/A
- CATX N/A
- EPS
- INSG 0.28
- CATX N/A
- Revenue
- INSG $174,015,000.00
- CATX $1,235,000.00
- Revenue This Year
- INSG N/A
- CATX N/A
- Revenue Next Year
- INSG $16.28
- CATX N/A
- P/E Ratio
- INSG $58.70
- CATX N/A
- Revenue Growth
- INSG 4.58
- CATX N/A
- 52 Week Low
- INSG $6.24
- CATX $1.60
- 52 Week High
- INSG $19.75
- CATX $12.90
- Technical
- Relative Strength Index (RSI)
- INSG 60.45
- CATX 34.46
- Support Level
- INSG $13.16
- CATX $2.60
- Resistance Level
- INSG $16.59
- CATX $3.15
- Average True Range (ATR)
- INSG 1.00
- CATX 0.35
- MACD
- INSG -0.00
- CATX -0.15
- Stochastic Oscillator
- INSG 89.37
- CATX 1.97
About INSG Inseego Corp.
Inseego Corp is into the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by applications software and cloud services designed to enable customers to easily analyze data insights and configure and manage their hardware. It generates maximum revenue from United States and Canada. The company also has a presence in Australia and Europe (including United Kingdom).
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.